| Marianne Sacasa De Strasberg, MD | |
|
701 Grove Rd Fl 1, Greenville, SC 29605-4210 | |
| (864) 455-7899 | |
| (864) 455-5474 |
| Full Name | Marianne Sacasa De Strasberg |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 13 Years |
| Location | 701 Grove Rd Fl 1, Greenville, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023397247 | NPI | - | NPPES |
| 817432 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 81743 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prisma Health Baptist Easley Hospital | Easley, SC | Hospital |
| Prisma Health Greenville Memorial Hospital | Greenville, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prisma Health University Medical Group | 8325950983 | 2201 |
News Archive
At least 58 U.S. abortion clinics - almost 1 in 10 - have shut or stopped providing the procedure since 2011 as access vanishes faster than ever amid a Republican-led push to legislate the industry out of existence. A wave of regulations that makes it too expensive or logistically impossible for facilities to remain in business drove at least a third of the closings (Deprez, 9/3).
The assisted-suicide advocate, who was also a physician, used lethal chemicals and an Oregon law he helped pass to end his own life. He was 83.
In a paper published in the November 9 issue of The Journal of Neuroscience, researchers at the University of California, San Diego School of Medicine and University of Washington describe in deeper detail the pathology of a devastating neurological disorder, but also reveal new cellular targets for possibly slowing its development.
This first randomized clinical study of a polymer-coated zotarolimus-eluting stent (Resolute Onyx) that utilizes a novel thin-strutted metallic platform allowing for better x-ray visibility was shown to be non-inferior to an ultrathin-strutted bioresorbable polymer-coated sirolimus-eluting stent (Orsiro) that uses a cobalt-chromium strut platform.
The U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) seeking marketing approval for Retigabine. In addition, the European Medicines Agency (EMEA) confirmed on November 17, 2009 that the MAA (Marketing Authorization Application) was successfully validated thus enabling the MAA review to commence.
› Verified 5 days ago
| Entity Name | Prisma Health University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295763217 PECOS PAC ID: 8325950983 Enrollment ID: O20031103000238 |
News Archive
At least 58 U.S. abortion clinics - almost 1 in 10 - have shut or stopped providing the procedure since 2011 as access vanishes faster than ever amid a Republican-led push to legislate the industry out of existence. A wave of regulations that makes it too expensive or logistically impossible for facilities to remain in business drove at least a third of the closings (Deprez, 9/3).
The assisted-suicide advocate, who was also a physician, used lethal chemicals and an Oregon law he helped pass to end his own life. He was 83.
In a paper published in the November 9 issue of The Journal of Neuroscience, researchers at the University of California, San Diego School of Medicine and University of Washington describe in deeper detail the pathology of a devastating neurological disorder, but also reveal new cellular targets for possibly slowing its development.
This first randomized clinical study of a polymer-coated zotarolimus-eluting stent (Resolute Onyx) that utilizes a novel thin-strutted metallic platform allowing for better x-ray visibility was shown to be non-inferior to an ultrathin-strutted bioresorbable polymer-coated sirolimus-eluting stent (Orsiro) that uses a cobalt-chromium strut platform.
The U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) seeking marketing approval for Retigabine. In addition, the European Medicines Agency (EMEA) confirmed on November 17, 2009 that the MAA (Marketing Authorization Application) was successfully validated thus enabling the MAA review to commence.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marianne Sacasa De Strasberg, MD 300 E Mcbee Ave Fl 4, Greenville, SC 29601-2842 Ph: (864) 522-8603 | Marianne Sacasa De Strasberg, MD 701 Grove Rd Fl 1, Greenville, SC 29605-4210 Ph: (864) 455-7899 |
News Archive
At least 58 U.S. abortion clinics - almost 1 in 10 - have shut or stopped providing the procedure since 2011 as access vanishes faster than ever amid a Republican-led push to legislate the industry out of existence. A wave of regulations that makes it too expensive or logistically impossible for facilities to remain in business drove at least a third of the closings (Deprez, 9/3).
The assisted-suicide advocate, who was also a physician, used lethal chemicals and an Oregon law he helped pass to end his own life. He was 83.
In a paper published in the November 9 issue of The Journal of Neuroscience, researchers at the University of California, San Diego School of Medicine and University of Washington describe in deeper detail the pathology of a devastating neurological disorder, but also reveal new cellular targets for possibly slowing its development.
This first randomized clinical study of a polymer-coated zotarolimus-eluting stent (Resolute Onyx) that utilizes a novel thin-strutted metallic platform allowing for better x-ray visibility was shown to be non-inferior to an ultrathin-strutted bioresorbable polymer-coated sirolimus-eluting stent (Orsiro) that uses a cobalt-chromium strut platform.
The U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) seeking marketing approval for Retigabine. In addition, the European Medicines Agency (EMEA) confirmed on November 17, 2009 that the MAA (Marketing Authorization Application) was successfully validated thus enabling the MAA review to commence.
› Verified 5 days ago
Dr. Amber Gist Laney, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Grove Rd Fl 1, Greenville, SC 29605 Phone: 864-455-7899 Fax: 864-455-5474 | |
Dr. Brent Alexander Oldham, MD, MPH Emergency Medicine Medicare: Medicare Enrolled Practice Location: 701 Grove Rd Fl 1, Greenville, SC 29605 Phone: 864-455-7899 Fax: 864-455-5474 | |
Christopher Steven Vega, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 701 Grove Rd, Greenville, SC 29605 Phone: 864-455-6371 | |
Dr. Ronald Gerard Pirrallo, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Grove Rd Fl 1, Greenville, SC 29605 Phone: 864-455-7899 Fax: 864-455-5474 | |
Dr. Frank J Ferlisi, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 701 Grove Rd, Greenville, SC 29605 Phone: 864-455-7157 | |
Dr. Kevin John Gregg, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Grove Rd, Department Of Emergency Medicine, Greenville, SC 29605 Phone: 864-455-7157 | |
Manuel Antonia De Pina, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1025 Verdae Blvd, Suite B, Greenville, SC 29607 Phone: 864-286-7550 |